Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to modulate painIn both ...

The annual meeting of the Post-Acute Long-Term Care Medical Association (PALTmed) will run March 26-28 in Anaheim.

When we are ill, we need expertise more than ever, yet our agency feels fragile. The best clinicians recognize this, a ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

Hospitals and health systems nationwide are facing an acute care workforce crisis. The lasting impacts of the pandemic, rising patient acuity, widespread clinician burnout and ongoing workforce ...

Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...

Lawmakers approved $16.7 million to seed new residency programs at St. Joseph’s/Candler to train and retain doctors for ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that it has completed the required enrollment in the ...

Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...

During the COVID-19 pandemic, there were global concerns that children with cancer might experience delayed diagnoses and disruptions to treatment, which in turn could worsen prognosis. However, a new ...

Testosterone replacement therapy (TRT) before total knee arthroplasty (TKA) is associated with an increased risk for medical and periprosthetic complications, a ...

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...